Exploring phosphatase and tensin homolog (PTEN) loss as a potential predictive marker for response to everolimus in patients with pancreatic neuroendocrine tumors (PNETs)

Category Primary study
JournalMolecular Cancer Therapeutics
Year 2015
This article has no abstract
Epistemonikos ID: fc0f6fa9c24dfc549bcff269cffa4f6b9f127d7f
First added on: Feb 08, 2025